⚡ Article Synopsis: In this article, OracleBio’s Senior Business Development Manager, Keith Bowers, explains our new contracting model to supply trained image analysis resource to the computational pathology departments of Pharma and Biotech. The benefits of this...
.
2023 Wrapped: OracleBio’s Year in Review
⚡ Article Synopsis: In this article, Senior Marketing Manager, Mark Laurie, wraps up OracleBio's highlights and achievement of 2023, and gives you a glimpse of what's to come in 2024.As 2023 draws to a close, and as is our annual OracleBio tradition, we reflect on...
AI-augmented and Pathologist-guided quantification of morphologically distinct cells in tumor tissue
⚡ Article Synopsis: In this article, OracleBio Senior Clinical Pathologist, Dr. James Going, provides an overview of how cell counting methods in cancer research have evolved. James focuses on a recent project that uses AI to improve the accuracy of macrophage...
Spatial Phenotyping in Digital Pathology: Defining a multiplex IF image analysis workflow to expedite translational and clinical R&D
⚡ Article Synopsis: In this article, OracleBio CSO, Lorcan Sherry, discusses the significance of spatial data generation from multiplex immunofluorescence (mIF) stained tissue sections, the application of a standardized image analysis workflow, how new innovations are...
Overcoming image co-registration challenges for accurate tissue classification on single IHC-stained samples
⚡ Article Synopsis: In this article, image analyst Hannah Macleod dives deep into the nuances of classifying tissue ROIs on single IHC and explores the transformative potential of image co-registration; from understanding its foundation to evaluating its real-world...
Our thoughts on the recent Visiopharm software updates (version 2023.01)
⚡ Article Synopsis: In this article, image analysis scientist Matthew McFarlane shares his thoughts on some of the recent Visiopharm software updates, how they work, and their benefits.With the rapid advancement into the era of precision medicine, digital pathology is...
Generating Quantitative Digital Pathology Data from Clinical R&D Studies to a Regulatory Standard
⚡ Article Synopsis: This latest article is part 2 of our recent Good Clinical Practice (GCP) service update — our GCP team takes a deeper dive into the ‘what, why, and how’ of GCP image analysis and how data generated to a regulatory standard can add value in...
OracleBio adds HALO AI Quantitative Digital Pathology capabilities to support Clinical R&D Data Generation to a Regulatory Standard
⚡ Article Synopsis: In this latest article, our GCP team talks about the exciting next phase of our Good Clinical Practice services, which have now launched. Expect to learn more about the client benefits. the process of analysing histology images to a regulatory...
Staining and Morphology Factors that can impact accurate AI-driven Nuclear Segmentation
⚡ Article Synopsis: In this article, OracleBio's Chief Scientific Officer, Lorcan Sherry, discusses the intricacies of AI-driven nuclear segmentation and the crucial factors that influence its accuracy in detecting and segmenting nuclei in tissues and cells.Over the...
Confirming AI Decisions: Utilising Indica Labs HALO v3.5 Validation to Strengthen OracleBio’s Classifier Validation Workflow
⚡ Article Synopsis: In this article, OracleBio Image Analysis Scientist, Caitlin Rutherford, highlights how Indica Labs HALO v3.5 validation workflow aids us in streamlining our internal algorithm validation process and explains how we would utilise this workflow in a...
An Image Analysis Study in Numbers: QDP Workflows, IT Infrastructure & Overcoming Technical Challenges
⚡ Article Synopsis: In this latest article, Senior Image Analysis Scientist, Chiara Asselborn shares her insight into OracleBio's Quantitative Digital Pathology workflow, the importance of a robust IT infrastructure, and how it helped overcome technical challenges...
A Pathologist’s Perspective: From Microscopy to Digital Pathology in a Changing World
⚡ Article Synopsis: In this article, OracleBio Senior Clinical Pathologist, Dr. James Going, discusses the history of microscopy and his experiences throughout his career; exploring how advancements in technology have both challenged and strengthened the field, and...
2022 Wrapped – OracleBio’s Year in Review
⚡ Article Synopsis: In this article, OracleBio's Marketing Manager, Mark Laurie, wraps up some of this year’s highlights and gives you a peek at what’s to come in 2023!As 2022 draws to a close, it’s a good time to reflect on the year and appreciate how much we’ve...
6 Ways to Improve the Quality of Quantitative Histopathology Data in 2022
⚡ Article Synopsis: In this article, OracleBio's Deputy Clinical Operations Manager, Nicole Couper, outlines 6 of the most prevalent issues encountered in Histopathology that hinder or negatively impact data quality.The generation of high-quality and robust...
Improving multiplex IF image analysis workflows: Does the perfect solution to autofluorescence exist?
⚡ Article Synopsis: In this article, OracleBio Image Analysis Scientist - Cristina Suanno, discusses ways to overcome autofluorescence, a common issue associated with multiplex immunofluorescent stained images.There are measures that can be taken at the tissue...